Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Caitlin Baten

3 papers in the library · 2 citations · publishing 2026

Papers

Ketamine pharmacotherapy for major depressive disorder: A narrative review

Progress in Neuro-psychopharmacology and Biological Psychiatry February 27, 2026 Chris H. Miller, Angela Hickman, Caitlin Baten et al. 2 citations

Ketamine, originally developed as an anesthetic, has emerged as a novel treatment for major depressive disorder (MDD) and treatment-resistant depression (TRD). Its antidepressant properties were discovered serendipitously, leading to FDA approval for TRD and MDD with suicidal ideation. The drug acts primarily as an NMDA receptor antagonist, triggering a paradoxical AMPA-mediated glutamate surge that promotes synaptogenesis and neuroplasticity. Intravenous ketamine and intranasal esketamine differ in dosing, bioavailability, and onset. Common adverse effects include dissociation, sedation, and hypertension. Efficacy studies show mixed-to-positive results, with non-inferiority to established treatments like electroconvulsive therapy. Future research aims to develop predictive markers for personalized medicine.

Major Depressive Disorder in Youth and Adults: A Quantitative Whole-Brain Meta-Analysis of Functional Magnetic Resonance Imaging Studies.

Biological psychiatry. Cognitive neuroscience and neuroimaging January 13, 2026 Caitlin Baten, Gladys Zamora, Amanda M. Klassen et al.

A meta-analysis of 135 fMRI studies involving 6,391 participants found that youth and adults with major depressive disorder (MDD) show different patterns of brain activation during tasks. Compared to adults with MDD, youth with MDD had distinct activation differences in the subgenual anterior cingulate cortex (sgACC) and dorsolateral prefrontal cortex (dlPFC). After controlling for illness duration, youth showed less activation than adults with shorter-duration MDD in regions like the sgACC. Among adults, those with longer-duration MDD showed less activation in the dlPFC compared to those with shorter-duration MDD. These results suggest that both age and length of illness matter for understanding brain changes in depression.

The functional neuroimaging of meditation: A quantitative whole-brain meta-analysis and systematic review.

Neuroscience and Biobehavioral Reviews July 1, 2026 Caitlin Baten, Arielle S Keller, Chris H. Miller et al.

A quantitative whole-brain meta-analysis of 34 fMRI studies involving 700 individuals examined four meditation practices: focused attention, open monitoring, mantra, and loving-kindness. Consistent activation across practices appeared in the rolandic operculum, insula, superior temporal gyrus, supplementary motor area, and hippocampus. Functional decoding linked meditation engagement to self-monitoring, reappraisal, motivation, experience, and awareness states. Meta-analytic comparisons revealed distinct neural patterns unique to each practice. These findings provide the most robust scientific characterization of the neural mechanisms of meditative states to date, setting the stage for future research into advanced meditation and clearer phenomenological characterization.